Stakeholder perspectives on the demand and supply factors driving substandard and falsified blood pressure lowering medications in Nigeria: a qualitative study.
Grace ShedulOlutobi Adekunle SanuadeEugenia N UgwunejiTunde M OjoAishwarya VijayPatrick PonzingInuwa OkpeGabriel Lamkur ShedulMark D HuffmanDike OjjiLisa R HirschhornPublished in: BMJ open (2022)
Our findings suggest that demand for and supply of SF BP lowering medications in Nigeria are driven by multi-level, interrelated factors. Multi-pronged strategies need to target stakeholders and systems involved in drug production, distribution, prescription, consumption, regulation and pricing.